Discovering biomarkers for non-alcoholic fatty liver

被引：0
|
作者：
Amri, J. [1 ,2 ]
Alaee, M. [3 ]
Salehi, M. [3 ]
机构：
[1] Univ Tehran Med Sci, Dept Clin Biochem, Fac Med, Tehran, Iran
[2] Univ Tehran Med Sci, Students Sci Res Ctr SSRC, Tehran, Iran
[3] Arak Univ Med Sci, Valiasr Hosp, Arak, Iran
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118844
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P0165
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] The Metabolomics of Non-Alcoholic Fatty Liver Disease: Of Networks and Biomarkers
    McGlinchey, Aidan
    Geng, Dawei
    Govaere, Olivier
    Ratziu, Vlad
    Bugianesi, Elisabetta
    Schattenberg, Joern M.
    Daley, Ann
    Hyotylainen, Tuulia
    Anstee, Quentin
    Oresic, Matej
    JOURNAL OF HEPATOLOGY, 2021, 75 : S579 - S580
  • [2] Metabolomic Biomarkers in the Diagnosis of Non-Alcoholic Fatty Liver Disease
    Chashmniam, Saeed
    Ghafourpour, Mohsen
    Farimani, Azam Rezaei
    Gholami, Ali
    Ghoochani, Bibi Fatemeh Nobakht Motlagh
    HEPATITIS MONTHLY, 2019, 19 (09)
  • [3] NON-ALCOHOLIC FATTY LIVER
    Carretto, Federico
    REVISTA MEDICA DE ROSARIO, 2021, 87 (02): : 87 - 88
  • [4] Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
    Basheer, Maamon
    Naffaa, Mohamed
    Assy, Nimer
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) : 398 - 400
  • [5] Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observations
    Solga, SF
    Alkhuraishe, A
    Cope, K
    Tabesh, A
    Clark, JM
    Torbenson, M
    Schwartz, P
    Magnuson, T
    Diehl, AM
    Risby, TH
    BIOMARKERS, 2006, 11 (02) : 174 - 183
  • [6] Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
    Svegliati-Baroni, Gianluca
    Pierantonelli, Irene
    Torquato, Pierangelo
    Marinelli, Rita
    Ferreri, Carla
    Chatgilialoglu, Chryssostomos
    Bartolini, Desiree
    Galli, Francesco
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 144 : 293 - 309
  • [7] Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease
    Yoshio, Sachiyo
    Kanto, Tatsuya
    IMMUNOLOGICAL MEDICINE, 2021, 44 (03) : 175 - 186
  • [8] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [9] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [10] Non-alcoholic fatty liver and cancer
    Ajit Venniyoor
    Indian Journal of Gastroenterology, 2020, 39 : 303 - 303
12345